House Subcommittee on Health Holds Hearing on MACRA
On March 21, the House Ways and Means Subcommittee on Health held a hearing focused on the implementation of the Medicare Access…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
March 2018
House Finally Passes Right to Try. If First You Don’t Succeed, Try, Try…
The United States Senate previously approved legislation that would allow the terminally ill to access experimental…
FDA Transparency Blueprint Issued
Most everyone even tangentially related to the pharmaceutical industry knows and understands that right now,…
Oregon: Transparency’s Latest Frontier
On March 13, 2018, Oregon Governor Kate Brown signed a bill that requires drugmakers to reportresearch and development and…
Alere Settles False Claims Act Allegations for $33.2 Million
Massachusetts-based medical device manufacturer Alere (acquired by Abbott Laboratories in 2017) and its subsidiary Alere San Diego…
NQF Issues Guidance on Opioid Prescribing Practices
The National Qualify Forum (NQF) recently released new guidelines to support safe and appropriate opioid prescribing to…
Teva and McCaskill: A Game of Cat and Mouse
In Summer 2017, we wrote about Senator Claire McCaskill’s request to Teva Pharmaceutical Industries that they provide…
Preparing for the 2018 Ethical MedTech, APACMed, and China Codes
The Healthcare Convention & Exhibitors Association (HCEA) presented a webinar, “Preparing for the 2018 Ethical…
Prime Therapeutics Proves PBMs’ Value
On February 20, 2018, Prime Therapeutics issued a press release that highlighted the way it – as a leading pharmacy benefit…
ACCME Announces New Collaboration with ABPath
The Accreditation Council for Continuing Medical Education (ACCME) and the American Board of Pathology (ABPath) are pleased to…